Cite
HARVARD Citation
Maini, R. et al. (n.d.). Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis. Annals of the rheumatic diseases. pp. I56-I60. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Maini, R. et al. (n.d.). Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis. Annals of the rheumatic diseases. pp. I56-I60. [Online].